iSpecimen Statistics
Share Statistics
iSpecimen has 962.64K shares outstanding. The number of shares has increased by -89.41% in one year.
| Shares Outstanding | 962.64K |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 47% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 823.18K |
| Failed to Deliver (FTD) Shares | 2.00K |
| FTD / Avg. Volume | 0.4% |
Short Selling Information
The latest short interest is 95.32K, so 9.9% of the outstanding shares have been sold short.
| Short Interest | 95.32K |
| Short % of Shares Out | 9.9% |
| Short % of Float | 11.58% |
| Short Ratio (days to cover) | 0.37 |
Valuation Ratios
The PE ratio is -8.15 and the forward PE ratio is -5.67.
| PE Ratio | -8.15 |
| Forward PE | -5.67 |
| PS Ratio | 9.12 |
| Forward PS | 0.1 |
| PB Ratio | 9.29 |
| P/FCF Ratio | -8.58 |
| PEG Ratio | n/a |
Enterprise Valuation
iSpecimen Inc. has an Enterprise Value (EV) of 2.38M.
| EV / Earnings | -0.21 |
| EV / Sales | 0.24 |
| EV / EBITDA | -0.26 |
| EV / EBIT | -0.21 |
| EV / FCF | -0.23 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.
| Current Ratio | 1.36 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | -48.4 |
Financial Efficiency
Return on equity (ROE) is -1.14% and return on capital (ROIC) is -112.4%.
| Return on Equity (ROE) | -1.14% |
| Return on Assets (ROA) | -0.7% |
| Return on Capital (ROIC) | -112.4% |
| Revenue Per Employee | 187.32K |
| Profits Per Employee | -209.42K |
| Employee Count | 53 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -73.6% in the last 52 weeks. The beta is 1.59, so iSpecimen 's price volatility has been higher than the market average.
| Beta | 1.59 |
| 52-Week Price Change | -73.6% |
| 50-Day Moving Average | 3.74 |
| 200-Day Moving Average | 5.1 |
| Relative Strength Index (RSI) | 36.12 |
| Average Volume (20 Days) | 496.39K |
Income Statement
In the last 12 months, iSpecimen had revenue of 9.93M and earned -11.10M in profits. Earnings per share was -1.23.
| Revenue | 9.93M |
| Gross Profit | 5.11M |
| Operating Income | -11.17M |
| Net Income | -11.10M |
| EBITDA | -9.10M |
| EBIT | -11.17M |
| Earnings Per Share (EPS) | -1.23 |
Balance Sheet
The company has 2.34M in cash and 196.24K in debt, giving a net cash position of 2.15M.
| Cash & Cash Equivalents | 2.34M |
| Total Debt | 196.24K |
| Net Cash | 2.15M |
| Retained Earnings | -59.36M |
| Total Assets | 11.26M |
| Working Capital | -1.61M |
Cash Flow
In the last 12 months, operating cash flow was -5.81M and capital expenditures -4.74M, giving a free cash flow of -10.55M.
| Operating Cash Flow | -5.81M |
| Capital Expenditures | -4.74M |
| Free Cash Flow | -10.55M |
| FCF Per Share | -1.17 |
Margins
Gross margin is 51.45%, with operating and profit margins of -112.5% and -111.8%.
| Gross Margin | 51.45% |
| Operating Margin | -112.5% |
| Pretax Margin | -111.8% |
| Profit Margin | -111.8% |
| EBITDA Margin | -91.7% |
| EBIT Margin | -112.5% |
| FCF Margin | -106.28% |
Dividends & Yields
ISPC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -46.59% |
| FCF Yield | -415.78% |
Analyst Forecast
Currently there are no analyst rating for ISPC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 16, 2024. It was a backward split with a ratio of 1:20.
| Last Split Date | Sep 16, 2024 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -9.96 |
| Piotroski F-Score | 2 |